Document is current
Any future updates will be listed below
-
Authors
Holm, Jonas Busk
Bruun, Jens Meldgaard
Christiansen, Peer
Thomsen, Reimar Wernich
Frystyk, Jan
Cronin-Fenton, Deirdre
Borgquist, Signe
-
Funding
Funding for this research was provided by:
NEYE Foundation
Kræftens Bekæmpelse (R288-A16168, R327-A19070)
Department of Oncology Research Foundation
Novo Nordisk Foundation STENO Collaborative Grant (NNF20OC0065928)
Fagerlund Stiftelsen
- License Information
-
More Information
Article History
Received: 6 January 2025
Accepted: 8 April 2025
First Online: 28 April 2025
Declarations
:
: The Danish National Committee on Health Research Ethics approved this study (no. 1-10-72-192-20). Informed consent was obtained from all included participants. All experiments were performed in accordance with relevant guidelines and regulations.
: Not applicable.
: JMB has been part of speakers bureaus and/or received research support from Boehringer Ingelheim, Eli Lilly, MSD/Merck, and Novo Nordisk. RWT has given presentations and lectures on medical research (both with and without financial compensation) for various companies, including AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, and Sanofi. JBH, PC, JF, DCF, and SB have no personal conflicts of interest to declare.
